Analyst Ratings for Reviva Pharmaceuticals (RVPH)
RVPH Rating Summary
RVPH Price Target Summary
- Highest: $20.00 (H.C. Wainwright)
- Lowest: $12.00 (Roth/MKM)
- Average: $16.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.67 (+451.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$16.67 (+451.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/20/2023 | Roth/MKM | Scott Henry | New Coverage | Buy (N/A) |
12.00 (N/A) |
5.40 (3.02) |
-44.07% | Details |
| 6/8/2023 | Benchmark | Bruce Jackson | New Coverage | Speculative Buy (N/A) |
N/A (N/A) |
7.16 (3.02) |
-57.82% | Details |
 |
||||||||
|
||||||||
|
||||||||
